Fragile X Syndrome Market The global Fragile X Syndrome Market is developing as pharmaceutical companies, biotechnology firms, research institutions, and healthcare organizations increase efforts to understand the genetic and neurological mechanisms associated with Fragile X syndrome (FXS). According to Maximize Market Research, the market was valued at approximately USD 142.54 million in 2025...